Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
IMPACT THERAP-B
IMPACT THERAP-B (07630.HK): EU Approves Senaparib for Ovarian Cancer
Tags:
IMPACT THERAP-B
07630.HK
Ovarian Cancer
2026-11-17
Hong Kong Recently Listed Stocks Daily Report: DKE Rises 22.93% to Lead the Electronic Paper Theme, Pharmaceutical Names Mixed-20261113
Tags:
Hong Kong Recently Listed Stocks Daily Report
DKE
B&K CORP-B
IMPACT THERAP-B
2026-11-13
HK Stock Connect Insight | IMPACT THERAP-B (07630.HK) Reports 316.8% H1 Revenue Growth, Down 34.32% Since Stock Connect Inclusion
Tags:
IMPACT THERAP-B
07630.HK
HK Stock Connect
2026-11-11
IMPACT THERAP-B (07630.HK): Board Approves Up to HK$100m H-Share Buyback
Tags:
IMPACT THERAP-B
07630.HK
Share Buyback
2026-11-04
IMPACT THERAP-B (07630.HK): senaparib FLAMES median PFS hits 38.7 months
Tags:
IMPACT THERAP-B
07630.HK
NewTimeSpace
2026-10-23
HK Recently Listed Stocks Watch | IMPACT THERAP-B (07630.HK) down 9.59%, 13.93 million cornerstone shares to be unblocked on 13 November, ALLIST's furmonertinib misses Phase III primary endpoint
Tags:
NewTimeSpace
IMPACT THERAP-B
07630.HK
2026-10-08
Hong Kong Recently Listed Stocks Daily Report: Pharma and Semiconductors Take the Baton to Lead Gains, IMPACT THERAP-B Surges 27.78%; Liquidity Concentration at the Top Intensifies - 20260921
Tags:
Hong Kong Recently Listed Stocks Daily Report
Recently Listed Stocks
IMPACT THERAP-B
Z.AI
DELTON
2026-09-21
IMPACT THERAP-B (07630.HK): Sepalna Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Ovarian Cancer
Tags:
IMPACT THERAP-B
07630.HK
R&D Progress
2026-09-18
IMPACT THERAP-B (07630.HK): Interim revenue up 316.8% to RMB 105.2 million as Senaparib sales ramp up, loss narrows 29.5%
Tags:
IMPACT THERAP-B
07630.HK
NewTimeSpace
2026-09-14
IMPACT THERAP-B (07630.HK): H shares included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect lists effective 7 September
Tags:
IMPACT THERAP-B
07630.HK
Stock Connect
2026-09-07
IMPACT THERAP-B (07630.HK): Executive director and CEO increases stake with purchase of 100,000 shares, holding rises to approximately 6.564%
Tags:
IMPACT THERAP-B
07630.HK
Share Increase
2026-09-03
IMPACT THERAP-B (07630.HK): Nominates IMP2794 as preclinical candidate compound, first KAT6A-specific PROTAC from self-owned targeted protein degradation platform
Tags:
IMPACT THERAP-B
07630.HK
R&D Progress
2026-08-12
IMPACT THERAP-B (07630.HK): H1 Revenue Expected to Surge 276% to 359% with Loss Narrowing 22% to 37%, Driven by Senaparib's NRDL Inclusion
Tags:
IMPACT THERAP-B
07630.HK
loss narrowed
2026-08-11
IMPACT THERAP-B (07630.HK): Clinical Data of Senaparib, IMP1734 and IMP1707 Accepted for Poster Presentations at ESMO Congress 2026
Tags:
IMPACT THERAP-B
07630.HK
poster presentation
2026-07-20
Finance
IMPACT THERAP-B (07630.HK): EU Approves Senaparib for Ovarian Cancer
Finance
BANKOFZHENGZHOU (06196.HK): Redeems RMB10bn Perpetual Capital Bonds
Research
HK Stock Connect Daily Report: AKESO -22.11% after FDA CRL - 20261116
Research
Hong Kong Recently Listed Stocks Daily Report: METALIGHT Rises 32.27% to Lead, Computing Power Chip Theme Heats Up-20261116
Research
HK AI Concept Stock Daily: MINIMAX-W -18.04%; UBTECH JV Deal 20261116
Finance
SIHUAN PHARM (00460.HK): bireociclib indication added to national NRDL
Finance
51WORLD (06651.HK): kicks off Shenzhen A-share IPO with adviser
Finance
YANGTZEKIANG (00294.HK): interim loss seen down to HKD 13 million
Research
Offshore Trust Insight | LUK FOOK HOLD (00590.HK) Reports FY2025/26 Revenue of HKD 17.205 Billion; Founder Trust Holds About 40.65%
Finance
NewTimeSpace | HK Close: HSI +0.49%, Food & Consumer Themes Rise
Scan QR Code
Download App